STE STERIS plc (Ireland) Ordinary Shares
Über STERIS plc (Ireland) Ordinary Shares Unternehmensübersicht von Wikipedia
Die STERIS plc ist ein britisches Unternehmen für Sterilisation, Infektionsprävention, Desinfektion und Dekontamination mit Sitz in Derby und operativer Hauptzentrale in Mentor im US-Bundesstaat Ohio. Hauptabnehmer sind Krankenhäuser, wissenschaftliche Forschungseinrichtungen und Unternehmen der Pharmaindustrie.
Mehr lesen
Die STERIS plc ist ein britisches Unternehmen für Sterilisation, Infektionsprävention, Desinfektion und Dekontamination mit Sitz in Derby und operativer Hauptzentrale in Mentor im US-Bundesstaat Ohio. Hauptabnehmer sind Krankenhäuser, wissenschaftliche Forschungseinrichtungen und Unternehmen der Pharmaindustrie.
Die Aktien des Unternehmens werden an der New York Stock Exchange gehandelt.
## Geschichte
Das Unternehmen wurde 1985 als Innovative Medical Technologies gegründet und 1987 in Steris Corporation umbenannt. Zu dieser Zeit beschäftigte das Unternehmen fünf Mitarbeiter. Die Wurzeln des Unternehmens reichen jedoch bis zur 1894 gegründeten American Sterilizer Company.
1992 folgte der Börsengang an der NASDAQ, 1998 wechselte man zur New York Stock Exchange.
Die Geschichte von Steris ist vor allem durch Firmenübernahmen geprägt. Im Jahr 1996 übernahm Steris die Marke Amsco sowie die Unternehmen Surgicot, und Calgon Vestal Laboratories, 1997 Isomedix Services und Joslyn Sterilizer Corporation, 1998 dann Detach, Hausted und Royal Sterilization Systems sowie 1999 Quality Sterilization Services und FoodLabs. Mit der Übernahme von US Endoscopy, der Spectrum Surgical Instrument Corporation und Total
Repair Express war die Mitarbeiterzahl von Steris im Jahr 2012 bereits auf 5.000 Menschen in 60 Ländern angewachsen.
Im Jahr 2014 übernahm Steris die Integrated Medical Systems International, Eschmann Equipment, Florida Surgical Repair und Life Systems.
Im Oktober 2014 kündigte Steris an, seinen britischen Konkurrenten Synergy Health für 1,9 Milliarden US-Dollar zu übernehmen und seinen Sitz in das Vereinigte Königreich zu verlegen. Durch die Fusion wird ein Unternehmen mit weltweit 14.000 Mitarbeitern und einem Jahresumsatz von 2,6 Milliarden US-Dollar entstehen. Am 28. Mai 2015 stoppte die US-Aufsichtsbehörde FTC die Übernahme. Steris ging erfolgreich dagegen vor und verkündete am 24. September 2015, mit der Fusion fortzufahren. Am 2. November 2015 schloss Steris die Übernahme und die Sitzverlegung ins Vereinigte Königreich ab.
Im November 2018 gab Steris bekannt seinen Sitz vom Vereinigten Königreich nach Irland zu verlegen. Gründe sind der Brexit und niedrigere Steuern in Irland.
Im Juni 2021 wurde Cantel Medical Corporation übernommen.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
STE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
STE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag |
|---|---|
| 8. Juni 2026 | $0,6300 |
| 17. Februar 2026 | $0,6300 |
| 4. September 2025 | $0,6300 |
| 10. Juni 2025 | $0,5700 |
| 20. Februar 2025 | $0,5700 |
| 19. November 2024 | $0,5700 |
| 5. September 2024 | $0,5700 |
| 12. Juni 2024 | $0,5200 |
| 22. Februar 2024 | $0,5200 |
| 20. November 2023 | $0,5200 |
| 5. September 2023 | $0,5200 |
| 13. Juni 2023 | $0,4700 |
| 23. Februar 2023 | $0,4700 |
| 21. November 2022 | $0,4700 |
| 6. September 2022 | $0,4700 |
| 13. Juni 2022 | $0,4300 |
| 24. Februar 2022 | $0,4300 |
| 22. November 2021 | $0,4300 |
| 2. September 2021 | $0,4300 |
| 27. Mai 2021 | $0,4000 |
STE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 3 18,8%
- Kauf 8 50,0%
- Halten 5 31,2%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
8 Analysten · 2026-08-14Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $2.59 | $2.53 | 0.06% |
| 31. März 2026 | $2.83 | $2.88 | -0.05% |
| 31. Dezember 2025 | $2.53 | $2.56 | -0.03% |
| 30. September 2025 | $2.47 | $2.37 | 0.10% |
| 30. Juni 2025 | $2.34 | $2.29 | 0.05% |
| 31. März 2025 | $2.74 | $2.62 | 0.12% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| STE | $21.63B | 27.9 | 8.7% | 13.2% | 11.3% | 44.2% |
| MDT | $106.66B | 22.3 | 8.4% | 13.2% | 9.8% | — |
| TRIB | — | — | — | — | — | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B | $3.03B | $2.78B | $2.62B | $2.61B | |
| Cost of Revenue | $3.31B | $3.06B | $2.92B | $2.56B | $2.34B | $1.76B | $1.71B | $1.61B | $1.53B | $1.59B | |
| Gross Profit | $2.63B | $2.40B | $2.22B | $1.98B | $1.88B | $1.34B | $1.32B | $1.17B | $1.09B | $1.03B | |
| R&D Expense | $113M | $108M | $104M | $98M | $87M | $66M | $66M | $63M | $61M | $59M | |
| SG&A Expense | $1.41B | $1.33B | $1.25B | $1.09B | $1.32B | $731M | $717M | $670M | $632M | $682M | |
| Operating Expenses | $1.52B | $1.54B | $1.38B | $1.19B | $1.41B | $795M | $783M | $764M | $693M | $800M | |
| Operating Income | $1.10B | $867M | $836M | $791M | $478M | $548M | $537M | $411M | $400M | $226M | |
| Interest Expense | · | · | $144M | $108M | $89M | $37M | $40M | $45M | $51M | $45M | |
| Other Non-op | $10M | $8M | $11M | $-3M | $6M | $6M | $2M | $3M | $6M | $3M | |
| Pretax Income | $1.05B | $796M | $703M | $680M | $367M | $518M | $499M | $369M | $355M | $185M | |
| Income Tax | $262M | $185M | $150M | $124M | $82M | $121M | $91M | $64M | $63M | $74M | |
| Net Income | $782M | $615M | $378M | $107M | $244M | $397M | $408M | $304M | $291M | $110M | |
| EPS (Basic) | $7.97 | $6.24 | $3.83 | $1.07 | $2.50 | $4.66 | $4.81 | $3.59 | $3.42 | $1.29 | |
| EPS (Diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 | $4.63 | $4.76 | $3.55 | $3.39 | $1.28 | |
| Shares (Basic) | 98,200,000 | 98,600,000 | 98,800,000 | 99,706,000 | 97,535,000 | 85,203,000 | 84,778,000 | 84,577,000 | 85,028,000 | 85,473,000 | |
| Shares (Diluted) | 98,700,000 | 99,100,000 | 99,400,000 | 100,246,000 | 98,326,000 | 85,898,000 | 85,641,000 | 85,468,000 | 85,713,000 | 86,094,000 | |
| EBITDA | $1.59B | $1.34B | $1.40B | $821M | $979M | $768M | $734M | $637M | · | · |
Bilanz 27
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $440M | $172M | $207M | $208M | $348M | $221M | $320M | $221M | $202M | $283M | |
| Receivables | $1.09B | $1.04B | $1.01B | $865M | $799M | $609M | $586M | $565M | $528M | · | |
| Inventory | $632M | $581M | $675M | $604M | $575M | $315M | $264M | $208M | $206M | · | |
| Current Assets | $2.39B | $2.00B | $2.87B | $2.01B | $1.88B | $1.21B | $1.22B | $1.05B | $990M | · | |
| PP&E (Net) | $2.16B | $1.96B | $1.77B | $1.63B | $1.55B | $1.24B | $1.11B | $1.03B | $1.01B | · | |
| PP&E (Gross) | $4.11B | $3.69B | $3.34B | $3.05B | $2.82B | $2.39B | $2.13B | $1.99B | $1.85B | · | |
| Accum. Depreciation | $1.94B | $1.73B | $1.57B | $1.41B | $1.27B | $1.15B | $1.02B | $956M | $841M | · | |
| Goodwill | $4.19B | $4.10B | $4.07B | $3.88B | $3.94B | $3.03B | $2.36B | $2.32B | $2.43B | $2.23B | |
| Intangibles | $1.62B | $1.85B | $2.12B | $2.08B | $3.33B | $898M | $565M | $605M | $727M | · | |
| Other Non-current Assets | $211M | $83M | $66M | $78M | $71M | $53M | $52M | $60M | $39M | · | |
| Total Assets | $10.74B | $10.15B | $11.06B | $10.82B | $11.42B | $6.57B | $5.44B | $5.07B | $5.20B | · | |
| Accounts Payable | $339M | $281M | $252M | $264M | $226M | $157M | $149M | $153M | $136M | · | |
| Accrued Liabilities | $402M | $368M | $320M | $298M | $307M | $221M | $192M | $188M | $168M | · | |
| Short-term Debt | $119M | $125M | $86M | $60M | $143M | $0 | $0 | · | · | · | |
| Current Liabilities | $1.15B | $1.02B | $931M | $862M | $922M | $578M | $504M | $465M | $398M | · | |
| Capital Leases | $120M | $125M | $146M | $140M | $155M | $130M | $114M | $0 | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | $151M | $160M | · | |
| Other Non-current Liabilities | $72M | $62M | $72M | $76M | $76M | $88M | $90M | $88M | $109M | · | |
| Total Liabilities | $3.54B | $3.53B | $4.75B | $4.73B | $4.88B | $2.68B | $2.02B | $1.89B | $1.98B | · | |
| Long-term Debt | $1.81B | $1.92B | $3.12B | $3.02B | $2.95B | $1.65B | $1.15B | $1.18B | $1.32B | · | |
| Total Debt | $1.93B | $2.04B | $3.21B | $3.08B | $3.09B | $1.65B | $1.15B | $1.18B | · | · | |
| Common Stock | $4.28B | $4.42B | $4.54B | $4.49B | $4.74B | $2.00B | $1.98B | $2.00B | $2.05B | · | |
| Retained Earnings | $3.02B | $2.48B | $2.09B | $1.91B | $2.00B | $1.94B | $1.66B | $1.34B | $1.15B | · | |
| AOCI | $-113M | $-292M | $-329M | $-321M | $-210M | $-61M | $-235M | $-160M | $12M | $-241M | |
| Stockholders' Equity | $7.18B | $6.60B | $6.30B | $6.08B | $6.53B | $3.88B | $3.41B | $3.18B | $3.21B | · | |
| Liabilities + Equity | $10.74B | $10.15B | $11.06B | $10.82B | $11.42B | $6.57B | $5.44B | $5.07B | $5.20B | · | |
| Shares Outstanding | 97,800,000 | 98,300,000 | 98,900,000 | 98,600,000 | 100,067,000 | 85,353,000 | 84,924,000 | 84,517,000 | 84,747,000 | · |
Cashflow 18
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $486M | $476M | $565M | $553M | $553M | $219M | $197M | $226M | $178M | $188M | |
| Stock-based Comp | $62M | $57M | $56M | $39M | $58M | $26M | $24M | $24M | $22M | $19M | |
| Deferred Tax | $-17M | $-76M | $-131M | $-186M | $-107M | $4M | $9M | $-7M | $-25M | $31M | |
| Amort. of Intangibles | $268M | $276M | $268M | $260M | $265M | $87M | $75M | $99M | $70M | $69M | |
| Restructuring | $3M | $62M | $44M | $485.0K | $48.0K | $-3M | $3M | $41M | $103.0K | $215.0K | |
| Other Non-cash | $28M | $76M | $105M | $244M | $-63M | $43M | $-48M | $-8M | · | · | |
| Operating Cash Flow | $1.34B | $1.15B | $973M | $757M | $685M | $690M | $591M | $540M | $458M | $424M | |
| CapEx | $369M | $370M | $360M | $362M | $288M | $239M | $215M | $190M | $165M | $173M | |
| Investing Cash Flow | $-512M | $389M | $-887M | $-383M | $-667M | $-1.15B | $-320M | $-213M | $-204M | $-104M | |
| Net Debt Issued | · | · | · | · | · | $-35M | $0 | $-85M | · | · | |
| Stock Repurchased | $236M | $211M | $12M | $309M | $56M | $15M | $51M | $81M | $65M | $98M | |
| Net Stock Activity | $-236M | $-211M | $-12M | $-309M | $-56M | $-15M | $-51M | $-81M | · | · | |
| Dividends Paid | $242M | $220M | $201M | $183M | $163M | $134M | $123M | $113M | $103M | $93M | |
| Financing Cash Flow | $-568M | $-1.57B | $-85M | $-499M | $116M | $346M | $-163M | $-295M | $-356M | $-267M | |
| Net Change in Cash | $268M | $-35M | $-1M | $-140M | $128M | $-99M | $99M | $19M | $-81M | $34M | |
| Taxes Paid | $289M | $274M | $271M | $255M | $138M | $110M | $92M | $65M | $86M | $78M | |
| Free Cash Flow | $972M | $778M | $613M | $395M | $397M | $450M | $376M | $350M | · | · | |
| Levered FCF | · | · | $499M | $322M | $328M | $422M | $343M | $313M | · | · |
Rentabilität 8
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.2% | 44.0% | 43.2% | 43.6% | 44.0% | 43.2% | 43.5% | 42.2% | · | · | |
| Operating Margin | 18.6% | 15.9% | 16.3% | 5.4% | 9.3% | 17.6% | 17.7% | 14.8% | · | · | |
| Net Margin | 13.2% | 11.3% | 7.4% | 2.2% | 5.3% | 12.8% | 13.5% | 10.9% | · | · | |
| Pretax Margin | 17.6% | 14.6% | 13.7% | 3.2% | 6.9% | 16.7% | 16.4% | 13.3% | · | · | |
| EBITDA Margin | 26.8% | 24.6% | 27.3% | 16.6% | 21.3% | 24.7% | 24.2% | 22.9% | · | · | |
| ROA | 7.5% | 5.8% | 3.5% | 0.96% | 2.7% | 6.6% | 7.8% | 5.9% | · | · | |
| ROE | 11.3% | 9.5% | 6.1% | 1.7% | 4.7% | 10.9% | 12.4% | 9.5% | · | · | |
| ROIC | 9.1% | 7.7% | 6.9% | 2.0% | 3.4% | 7.6% | 9.7% | 7.8% | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 2.0 | 3.1 | 2.3 | 2.0 | 2.1 | 2.4 | 2.3 | · | · | |
| Quick Ratio | 1.0 | 1.0 | 1.1 | 1.1 | 0.9 | 1.4 | 1.8 | 1.7 | · | · | |
| Debt / Equity | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 | · | · | |
| LT Debt / Equity | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 | 0.4 | 0.3 | 0.4 | · | · | |
| Interest Coverage | · | · | 5.8 | 2.5 | 4.8 | 14.7 | 13.3 | 9.1 | · | · |
Effizienz 3
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.6 | 0.5 | · | · | |
| Inventory Turnover | 5.5 | 4.9 | 4.6 | 4.4 | 5.8 | 6.1 | 7.5 | 7.8 | · | · | |
| Receivables Turnover | 5.6 | 5.3 | 5.5 | 5.7 | 6.5 | 5.2 | 5.3 | 5.1 | · | · |
Wachstumsraten 10
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.7% | 6.2% | 13.3% | 7.4% | 35.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 9.4% | 8.9% | 18.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 13.8% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 27.9% | 62.7% | 256.1% | -56.9% | -46.4% | · | · | · | · | · | |
| EPS CAGR 3Y | 95.0% | 35.7% | -6.3% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 11.4% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 27.3% | 62.5% | 253.4% | -56.1% | -38.6% | · | · | · | · | · | |
| Net Income CAGR 3Y | 94.1% | 36.1% | -1.6% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 14.5% | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 12.6% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 17
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B | $3.03B | $2.78B | · | · | |
| Net Income TTM | $782M | $615M | $378M | $107M | $244M | $397M | $408M | $304M | · | · | |
| Market Cap | $21.63B | $22.28B | $22.23B | $18.87B | $24.19B | $16.26B | $11.89B | $10.82B | · | · | |
| Enterprise Value | · | · | · | · | · | $17.69B | $12.72B | $11.78B | · | · | |
| P/E | 27.9 | 36.6 | 59.0 | 178.8 | 97.5 | 41.1 | 29.4 | 36.1 | · | · | |
| P/S | 3.6 | 4.1 | 4.3 | 4.2 | 5.7 | 5.2 | 3.9 | 3.9 | · | · | |
| P/B | 3.0 | 3.4 | 3.5 | 3.1 | 3.7 | 4.2 | 3.5 | 3.4 | · | · | |
| P / Tangible Book | 15.8 | 34.1 | 198.2 | 155.6 | · | · | · | · | · | · | |
| P / Cash Flow | 16.1 | 19.4 | 22.8 | 24.9 | 35.3 | 23.6 | 20.1 | 20.1 | · | · | |
| P / FCF | 22.2 | 28.6 | 36.3 | 47.8 | 60.9 | 36.1 | 31.6 | 30.9 | · | · | |
| EV / EBITDA | · | · | · | · | · | 23.0 | 17.3 | 18.5 | · | · | |
| EV / FCF | · | · | · | · | · | 39.3 | 33.8 | 33.7 | · | · | |
| EV / Revenue | · | · | · | · | · | 5.7 | 4.2 | 4.2 | · | · | |
| Dividend Yield | 1.1% | 0.99% | 0.90% | 0.97% | 0.67% | 0.82% | 1.0% | 1.0% | · | · | |
| Earnings Yield | 3.6% | 2.7% | 1.7% | 0.56% | 1.0% | 2.4% | 3.4% | 2.8% | · | · | |
| Payout Ratio | 30.9% | 35.8% | 53.0% | 171.4% | 66.9% | 33.7% | 30.2% | 37.0% | · | · | |
| Annual Payout | $242M | $220M | $201M | $183M | $163M | $134M | $123M | $113M | · | · |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.59B | $1.50B | $1.46B | $1.39B | $1.48B | $1.37B | $1.33B | $1.28B | $1.42B | $1.30B | $1.24B | $1.18B | $963M | $1.11B | $1.09B | |
| Cost of Revenue | $809M | $891M | $841M | $814M | $763M | $839M | $760M | $750M | $707M | $836M | $738M | $692M | $654M | $554M | $634M | $609M | |
| Gross Profit | $684M | $697M | $656M | $646M | $628M | $641M | $610M | $579M | $572M | $583M | $560M | $546M | $529M | $409M | $478M | $482M | |
| R&D Expense | $29M | $29M | $30M | $28M | $26M | $28M | $27M | $27M | $26M | $27M | $25M | $26M | $25M | $23M | $26M | $25M | |
| SG&A Expense | $370M | $352M | $352M | $350M | $354M | $334M | $336M | $329M | $336M | $309M | $308M | $328M | $307M | $128M | $305M | $323M | |
| Operating Expenses | $398M | $380M | $382M | $380M | $382M | $425M | $365M | $359M | $387M | $363M | $334M | $355M | $331M | $-339M | $331M | $839M | |
| Operating Income | $286M | $317M | $273M | $266M | $246M | $216M | $245M | $220M | $186M | $220M | $226M | $192M | $198M | $748M | $191M | $-306M | |
| Interest Expense | · | · | · | · | · | · | · | · | $30M | · | $39M | $37M | $32M | · | $29M | $26M | |
| Other Non-op | $3M | $3M | $3M | $2M | $2M | $4M | $2M | $1M | $1M | $6M | $2M | $1M | $1M | $321.0K | $-2M | $-524.0K | |
| Pretax Income | $274M | $304M | $258M | $253M | $232M | $197M | $229M | $195M | $175M | $191M | $190M | $156M | $167M | $718M | $172M | $159M | |
| Income Tax | $72M | $84M | $64M | $61M | $54M | $50M | $55M | $44M | $35M | $37M | $41M | $35M | $36M | $81M | $41M | $35M | |
| Net Income | $200M | $220M | $193M | $192M | $177M | $146M | $174M | $150M | $145M | $-1M | $141M | $115M | $124M | $187M | $124M | $-315M | |
| EPS (Basic) | · | $2.26 | $1.96 | $1.95 | $1.80 | $1.49 | $1.76 | $1.52 | $1.47 | $-0.01 | $1.42 | $1.17 | $1.25 | $1.87 | $1.24 | $-3.15 | |
| EPS (Diluted) | · | $2.24 | $1.96 | $1.94 | $1.79 | $1.48 | $1.75 | $1.51 | $1.46 | $-0.02 | $1.42 | $1.16 | $1.25 | $1.88 | $1.24 | $-3.15 | |
| Shares (Basic) | 97,600,000 | -196,800,000 | 98,200,000 | 98,400,000 | 98,400,000 | -197,500,000 | 98,500,000 | 98,700,000 | 98,900,000 | -197,495,000 | 98,802,000 | 98,785,000 | 98,708,000 | -200,061,000 | 99,716,000 | 99,969,000 | |
| Shares (Diluted) | 97,900,000 | -197,500,000 | 98,600,000 | 98,800,000 | 98,800,000 | -198,400,000 | 98,900,000 | 99,200,000 | 99,400,000 | -198,599,000 | 99,354,000 | 99,406,000 | 99,239,000 | -200,611,000 | 100,166,000 | 99,969,000 | |
| EBITDA | $410M | · | $273M | $266M | $365M | · | $245M | $220M | $298M | · | $216M | $186M | $327M | · | $191M | $-306M |
Bilanz 26
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $482M | · | $424M | $319M | $280M | · | $155M | $172M | $198M | · | $196M | $214M | $209M | · | $259M | $258M | |
| Receivables | $1.01B | $1.09B | $991M | $947M | $947M | $1.04B | $915M | $923M | $893M | $1.01B | $964M | $940M | $888M | · | $823M | $780M | |
| Inventory | $712M | $632M | $674M | $658M | $641M | $581M | $650M | $689M | $699M | $675M | $856M | $821M | $769M | · | $694M | $645M | |
| Current Assets | $2.45B | $2.39B | $2.29B | $2.11B | $2.06B | $2.00B | $1.90B | $1.94B | $1.94B | $2.87B | $2.22B | $2.17B | $2.03B | · | $1.98B | $1.89B | |
| PP&E (Net) | $2.17B | $2.16B | $2.13B | $2.09B | $2.05B | $1.96B | $1.92B | $1.93B | $1.83B | $1.77B | $1.84B | $1.74B | $1.73B | · | $1.67B | $1.57B | |
| PP&E (Gross) | $4.17B | $4.11B | $4.05B | $3.96B | $3.87B | $3.69B | $3.61B | $3.60B | $3.44B | $3.34B | $3.41B | $3.25B | $3.20B | · | $3.06B | $2.90B | |
| Accum. Depreciation | $2.00B | $1.94B | $1.92B | $1.86B | $1.82B | $1.73B | $1.68B | $1.67B | $1.61B | $1.57B | $1.56B | $1.51B | $1.48B | · | $1.38B | $1.32B | |
| Goodwill | $4.19B | $4.19B | $4.23B | $4.22B | $4.22B | $4.10B | $4.04B | $4.15B | $4.06B | $4.07B | $4.11B | $4.04B | $3.89B | $3.88B | $3.85B | $3.71B | |
| Intangibles | $1.56B | $1.62B | $1.69B | $1.75B | $1.82B | $1.85B | $1.92B | $2.00B | $2.05B | $2.12B | $2.99B | $3.06B | $2.87B | · | $3.03B | $3.08B | |
| Other Non-current Assets | $215M | $211M | $94M | $88M | $89M | $83M | $68M | $60M | $63M | $66M | $77M | $73M | $80M | · | $80M | $72M | |
| Total Assets | $10.74B | $10.74B | $10.59B | $10.41B | $10.40B | $10.15B | $10.01B | $10.24B | $10.11B | $11.06B | $11.44B | $11.28B | $10.78B | · | $10.80B | $10.49B | |
| Accounts Payable | $344M | $339M | $285M | $309M | $301M | $281M | $238M | $235M | $232M | $252M | $277M | $294M | $261M | · | $242M | $233M | |
| Accrued Liabilities | $420M | $402M | $405M | $360M | $371M | $368M | $335M | $307M | $287M | $320M | $318M | $307M | $333M | · | $303M | $304M | |
| Short-term Debt | $243M | $119M | $0 | $0 | $0 | $125M | $125M | $80M | $80M | $86M | $78M | $71M | $63M | · | $60M | $151M | |
| Current Liabilities | $1.28B | $1.15B | $922M | $889M | $927M | $1.02B | $891M | $805M | $834M | $931M | $914M | $873M | $887M | · | $796M | $873M | |
| Capital Leases | · | $120M | · | · | · | $125M | · | · | · | $146M | · | · | · | · | · | · | |
| Other Non-current Liabilities | $75M | $72M | $67M | $64M | $64M | $62M | $73M | $74M | $72M | $72M | $78M | $77M | $77M | · | $73M | $76M | |
| Total Liabilities | $3.51B | $3.54B | $3.42B | $3.39B | $3.44B | $3.53B | $3.58B | $3.63B | $3.74B | $4.75B | $5.01B | $5.09B | $4.61B | · | $4.75B | $4.68B | |
| Long-term Debt | $1.65B | $1.81B | $1.90B | $1.90B | $1.90B | $1.92B | $2.04B | $2.16B | $2.24B | $3.12B | $3.23B | $3.37B | $2.86B | · | $3.00B | $2.87B | |
| Total Debt | $1.89B | · | $1.90B | $1.90B | $1.90B | · | $2.16B | $2.24B | $2.32B | · | $3.31B | $3.44B | $2.92B | · | $3.06B | $3.02B | |
| Common Stock | $4.18B | $4.28B | $4.34B | $4.36B | $4.43B | $4.42B | $4.40B | $4.49B | $4.50B | $4.54B | $4.53B | $4.52B | $4.50B | · | $4.63B | $4.71B | |
| Retained Earnings | $3.15B | $3.02B | $2.86B | $2.73B | $2.60B | $2.48B | $2.39B | $2.27B | $2.18B | $2.09B | $2.13B | $2.05B | $1.98B | · | $1.77B | $1.70B | |
| AOCI | $-127M | $-113M | $-43M | $-76M | $-70M | $-292M | $-374M | $-166M | $-323M | $-329M | $-253M | $-387M | $-311M | $-321M | $-364M | $-598M | |
| Stockholders' Equity | $7.21B | $7.18B | $7.15B | $7.01B | $6.96B | $6.60B | $6.42B | $6.59B | $6.35B | $6.30B | $6.42B | $6.18B | $6.17B | · | $6.04B | $5.80B | |
| Liabilities + Equity | $10.74B | $10.74B | $10.59B | $10.41B | $10.40B | $10.15B | $10.01B | $10.24B | $10.11B | $11.06B | $11.44B | $11.28B | $10.78B | · | $10.80B | $10.49B | |
| Shares Outstanding | 97,500,000 | 97,800,000 | 98,100,000 | 98,100,000 | 98,500,000 | 98,300,000 | 98,245,000 | 98,708,000 | 98,799,000 | 98,900,000 | 98,808,000 | 98,789,000 | 98,781,000 | 98,629,000 | 99,401,000 | 99,868,000 |
Cashflow 15
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $124M | $123M | $122M | $122M | $119M | $122M | $126M | $115M | $113M | $134M | $141M | $152M | $138M | $142M | $138M | $134M | |
| Stock-based Comp | $13M | $13M | $16M | $21M | $12M | $10M | $15M | $21M | $12M | $9M | $15M | $21M | $12M | $9M | $9M | $12M | |
| Deferred Tax | $600.0K | $-17M | $-100.0K | $-100.0K | $0 | $-53M | $-2M | $21.0K | $-22M | $-131M | $808.0K | $-869.0K | $-445.0K | $-123M | $101.0K | $-68M | |
| Restructuring | · | $300.0K | $100.0K | $1M | $2M | $29M | $2M | $3M | $28M | $44M | $6.0K | $-23.0K | $19.0K | $359.0K | $38.0K | $62.0K | |
| Other Non-cash | $30M | · | · | · | $111M | · | · | · | $56M | · | · | · | $9M | · | · | · | |
| Operating Cash Flow | $367M | $335M | $298M | $288M | $420M | $261M | $333M | $251M | $304M | $255M | $291M | $146M | $281M | $216M | $206M | $104M | |
| CapEx | $88M | $90M | $99M | $86M | $94M | $71M | $89M | $102M | $108M | $91M | $119M | $83M | $67M | $71M | $92M | $83M | |
| Investing Cash Flow | $-108M | $-217M | $-98M | $-88M | $-108M | $-70M | $-124M | $-105M | $688M | $-96M | $-119M | $-606M | $-67M | $-78M | $-98M | $-98M | |
| Stock Repurchased | $116M | $74M | $50M | $100M | $11M | $200.0K | $100M | $46M | $64M | $359.0K | $2M | $489.0K | $9M | $155M | $84M | $45M | |
| Net Stock Activity | $-116M | · | · | · | $-11M | · | · | $-46M | $-64M | · | $-2M | $-489.0K | $-9M | · | $-84M | $-45M | |
| Dividends Paid | $61M | $62M | $62M | $62M | $56M | $56M | $56M | $56M | $51M | $51M | $51M | $51M | $46M | $47M | $47M | $47M | |
| Financing Cash Flow | $-214M | $-98M | $-98M | $-159M | $-213M | $-178M | $-214M | $-181M | $-999M | $-144M | $-198M | $470M | $-214M | $-192M | $-120M | $-45M | |
| Net Change in Cash | $43M | $16M | $104M | $40M | $108M | $16M | $-17M | $-26M | $-9M | $11M | $-18M | $5M | $257.0K | $-51M | $1M | $-58M | |
| Free Cash Flow | $280M | · | · | · | $326M | · | · | · | $196M | · | · | · | $215M | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | $171M | · | · | · | $189M | · | · | · |
Rentabilität 8
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.8% | · | 43.8% | 44.2% | 45.1% | · | 44.5% | 43.5% | 44.7% | · | 43.2% | 44.2% | 44.6% | · | 42.9% | 44.3% | |
| Operating Margin | 19.1% | · | 18.3% | 18.2% | 17.7% | · | 17.9% | 16.5% | 14.5% | · | 15.5% | 13.9% | 14.7% | · | 15.7% | -25.5% | |
| Net Margin | 13.4% | · | 12.9% | 13.1% | 12.8% | · | 12.7% | 11.3% | 11.4% | · | 10.1% | 8.6% | 9.6% | · | 10.2% | -26.3% | |
| Pretax Margin | 18.3% | · | 17.2% | 17.3% | 16.7% | · | 16.7% | 14.7% | 13.7% | · | 12.8% | 11.2% | 12.3% | · | 13.2% | -27.7% | |
| EBITDA Margin | 27.4% | · | 18.3% | 18.2% | 26.3% | · | 17.9% | 16.5% | 23.3% | · | 15.5% | 13.9% | 25.4% | · | 15.7% | -25.5% | |
| ROA | 1.9% | · | 1.9% | 1.9% | 1.7% | · | 1.6% | 1.4% | 1.4% | · | 1.3% | 1.1% | 1.1% | · | 1.1% | -2.8% | |
| ROE | 2.8% | · | 2.8% | 2.8% | 2.7% | · | 2.7% | 2.4% | 2.3% | · | 2.3% | 1.9% | 2.0% | · | 2.0% | -5.1% | |
| ROIC | 2.3% | · | 2.3% | 2.3% | 2.1% | · | 2.2% | 1.9% | 1.7% | · | 1.8% | 1.5% | 1.6% | · | 1.6% | -3.3% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | · | 2.5 | 2.4 | 2.2 | · | 2.1 | 2.4 | 2.3 | · | 2.4 | 2.5 | 2.3 | · | 2.5 | 2.2 | |
| Quick Ratio | 1.2 | · | 1.5 | 1.4 | 1.3 | · | 1.2 | 1.4 | 1.3 | · | 1.3 | 1.3 | 1.2 | · | 1.4 | 1.2 | |
| Debt / Equity | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.5 | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| LT Debt / Equity | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 6.1 | · | 5.5 | 5.0 | 5.8 | · | 6.7 | -11.7 |
Effizienz 3
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.1 | 1.1 | |
| Receivables Turnover | 1.5 | · | 1.6 | 1.6 | 1.5 | · | 1.5 | 1.4 | 1.4 | · | 1.6 | 1.6 | 1.6 | · | 1.5 | 1.6 |
Bewertung (TTM) 15
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5.84B | · | $5.72B | $5.55B | $5.37B | · | $5.40B | $5.33B | $5.23B | · | $5.00B | $4.82B | $4.67B | · | $4.47B | $4.56B | |
| Net Income TTM | $762M | · | $736M | $693M | $646M | · | $468M | $435M | $400M | · | $567M | $550M | $119M | · | $-28M | $-8M | |
| Market Cap | $20.53B | · | $24.87B | $24.27B | $23.66B | · | $20.20B | $23.94B | $21.69B | · | $21.72B | $21.68B | $22.22B | · | $18.36B | $16.61B | |
| Enterprise Value | $21.94B | · | $26.35B | $25.85B | $25.29B | · | $22.20B | $26.00B | $23.81B | · | $24.84B | $24.90B | $24.94B | · | $21.16B | $19.37B | |
| P/E | 28.3 | · | 34.1 | 35.4 | 36.9 | · | 43.6 | 55.4 | 54.5 | · | 38.5 | 39.7 | 184.4 | · | -636.9 | -1511.6 | |
| P/S | 3.5 | · | 4.3 | 4.4 | 4.4 | · | 3.7 | 4.5 | 4.1 | · | 4.3 | 4.5 | 4.8 | · | 4.1 | 3.6 | |
| P/B | 2.8 | · | 3.5 | 3.5 | 3.4 | · | 3.1 | 3.6 | 3.4 | · | 3.4 | 3.5 | 3.6 | · | 3.0 | 2.9 | |
| P / Tangible Book | 14.1 | · | 20.2 | 23.2 | 25.8 | · | 45.0 | 54.6 | 87.2 | · | · | · | · | · | · | · | |
| P / Cash Flow | 55.9 | · | · | · | 56.3 | · | · | · | 71.4 | · | · | · | 79.1 | · | · | · | |
| P / FCF | 73.4 | · | · | · | 72.5 | · | · | · | 110.9 | · | · | · | 103.6 | · | · | · | |
| EV / EBITDA | 53.6 | · | 96.4 | 97.3 | 69.2 | · | 90.5 | 118.4 | 79.8 | · | 114.9 | 134.0 | 76.3 | · | 110.9 | -63.2 | |
| EV / FCF | 78.5 | · | · | · | 77.5 | · | · | · | 121.7 | · | · | · | 116.2 | · | · | · | |
| EV / Revenue | 3.8 | · | 4.6 | 4.7 | 4.7 | · | 4.1 | 4.9 | 4.5 | · | 5.0 | 5.2 | 5.3 | · | 4.7 | 4.2 | |
| Earnings Yield | 3.5% | · | 2.9% | 2.8% | 2.7% | · | 2.3% | 1.8% | 1.8% | · | 2.6% | 2.5% | 0.54% | · | -0.16% | -0.07% | |
| Payout Ratio | 30.7% | · | · | · | 31.7% | · | · | · | 35.4% | · | · | · | 37.6% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Umsatz | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B |
| Bruttogewinnmarge % | 44.2% | 44.0% | 43.2% | 43.6% | 44.0% |
| Betriebsgewinnmarge % | 18.6% | 15.9% | 16.3% | 5.4% | 9.3% |
| Nettoergebnis | $782M | $615M | $378M | $107M | $244M |
| Verwässerte EPS | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
Bilanz
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.3 | 0.3 | 0.5 | 0.5 | 0.5 |
| Liquiditätsgrad | 2.1 | 2.0 | 3.1 | 2.3 | 2.0 |
| Quick Ratio | 1.0 | 1.0 | 1.1 | 1.1 | 0.9 |
Cashflow
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $972M | $778M | $613M | $395M | $397M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 894 Einreicher · $11.9B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 104 (+7 vs. Vorquartal) | 95 (-26 vs. Vorquartal) | 285 (+24 vs. Vorquartal) | 292 (-47 vs. Vorquartal) | +17.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1.349.102.196 | 6.406.906 | 11,34% | Aktien |
| STATE STREET CORP | $1.068.232.039 | 5.072.818 | 8,98% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.053.260.612 | 5.001.950 | 8,85% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $649.054.651 | 3.082.370 | 5,45% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $480.951.904 | 2.294.484 | 4,04% | Aktien |
| GENERATION INVESTMENT MANAGEMENT LLP | $480.246.578 | 2.280.698 | 4,03% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $463.300.325 | 2.200.220 | 3,89% | Aktien |
| Select Equity Group, L.P. | $398.955.608 | 1.894.646 | 3,35% | Aktien |
| Boston Partners | $286.745.448 | 1.361.795 | 2,41% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $256.445.622 | 1.217.864 | 2,15% | Aktien |
| NORGES BANK | $251.035.869 | 1.192.173 | 2,11% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $200.817.569 | 953.685 | 1,69% | Aktien |
| GOLDMAN SACHS GROUP INC | $180.188.960 | 855.720 | 1,51% | Aktien |
| VANGUARD GROUP INC | $139.288.198 | 549.417 | 1,17% | Aktien |
| Findlay Park Partners LLP | $138.494.626 | 657.713 | 1,16% | Aktien |
| LONDON CO OF VIRGINIA | $135.103.429 | 641.604 | 1,14% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $115.966.163 | 550.725 | 0,97% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $112.852.811 | 510.346 | 0,95% | Aktien |
| D. E. Shaw & Co., Inc. | $107.308.578 | 509.610 | 0,90% | Aktien |
| LOCUST WOOD CAPITAL ADVISERS, LLC | $95.991.742 | 455.866 | 0,81% | Aktien |
| ROYAL LONDON ASSET MANAGEMENT LTD | $89.099.538 | 423.135 | 0,75% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $87.947.244 | 417.663 | 0,74% | Aktien |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $78.455.434 | 372.586 | 0,66% | Aktien |
| Fenimore Asset Management Inc | $74.796.972 | 355.212 | 0,63% | Aktien |
| BANK OF AMERICA CORP /DE/ | $70.284.896 | 333.784 | 0,59% | Aktien |
| Williams Jones Wealth Management, LLC. | $70.088.652 | 332.852 | 0,59% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $66.103.000 | 313.924 | 0,56% | Aktien |
| Life Cycle Investment Partners Ltd | $63.595.720 | 302.017 | 0,53% | Aktien |
| Gotham Asset Management, LLC | $62.307.242 | 295.898 | 0,52% | Aktien |
| Swiss National Bank | $58.235.239 | 276.560 | 0,49% | Aktien |
| Legal & General Group Plc | $58.117.740 | 276.002 | 0,49% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $56.816.208 | 269.821 | 0,48% | Aktien |
| DIKER MANAGEMENT LLC | $54.241.000 | 257.593 | 0,46% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $53.078.340 | 252.070 | 0,45% | Aktien |
| Pictet Asset Management Holding SA | $50.845.496 | 241.466 | 0,43% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $48.248.536 | 229.133 | 0,41% | Aktien |
| BlackRock, Inc. | $47.960.687 | 227.766 | 0,40% | Aktien |
| CITADEL ADVISORS LLC | $47.328.977 | 224.766 | 0,40% | Aktien |
| Quantinno Capital Management LP | $46.722.825 | 221.887 | 0,39% | Aktien |
| RHUMBLINE ADVISERS | $45.807.492 | 217.541 | 0,38% | Aktien |
| Swedbank AB | $45.746.754 | 217.252 | 0,38% | Aktien |
| Clearbridge Investments, LLC | $44.634.318 | 211.969 | 0,38% | Aktien |
| Vanguard Global Advisers, LLC | $44.613.255 | 211.869 | 0,37% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $44.118.335 | 209.519 | 0,37% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $43.833.725 | 208.167 | 0,37% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $42.082.277 | 199.560 | 0,35% | Aktien |
| BOSTON FINANCIAL MANGEMENT LLC | $40.999.663 | 199.454 | 0,34% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $40.282.041 | 191.300 | 0,34% | Aktien |
| Qube Research & Technologies Ltd | $39.591.371 | 188.020 | 0,33% | Aktien |
| PFA Pension, Forsikringsaktieselskab | $39.185.704 | 186.093 | 0,33% | Aktien |
| SNYDER CAPITAL MANAGEMENT L P | $39.126.222 | 185.811 | 0,33% | Aktien |
| Sustainable Growth Advisers, LP | $38.520.412 | 182.934 | 0,32% | Aktien |
| Boston Trust Walden Corp | $38.324.582 | 182.004 | 0,32% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $37.830.036 | 171.076 | 0,32% | Aktien |
| California Public Employees Retirement System | $37.263.309 | 176.964 | 0,31% | Aktien |
| FIL Ltd | $36.125.810 | 171.562 | 0,30% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $36.000.425 | 170.967 | 0,30% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $35.680.917 | 165.442 | 0,30% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $34.667.192 | 164.635 | 0,29% | Aktien |
| HSBC HOLDINGS PLC | $33.968.521 | 161.317 | 0,29% | Aktien |
| SEB Asset Management AB | $29.436.823 | 139.796 | 0,25% | Aktien |
| Thematics Asset Management | $28.390.276 | 114.736 | 0,24% | Aktien |
| Coho Partners, Ltd. | $26.442.589 | 106.865 | 0,22% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $26.214.912 | 124.495 | 0,22% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $24.407.800 | 115.913 | 0,21% | Aktien |
| BENJAMIN EDWARDS INC | $23.591.496 | 112.014 | 0,20% | Aktien |
| Champlain Investment Partners, LLC | $23.000.561 | 109.230 | 0,19% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $22.902.857 | 108.766 | 0,19% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $22.786.422 | 74.970 | 0,19% | Aktien |
| Norinchukin Bank, The | $21.447.186 | 101.853 | 0,18% | Aktien |
| Bellevue Group AG | $21.031.100 | 99.877 | 0,18% | Aktien |
| BARCLAYS PLC | $20.880.333 | 99.161 | 0,18% | Aktien |
| Asset Management One Co., Ltd. | $20.870.335 | 94.394 | 0,18% | Aktien |
| Eurizon Capital SGR S.p.A. | $20.735.895 | 98.464 | 0,17% | Aktien |
| Rathbones Group PLC | $20.637.333 | 98.007 | 0,17% | Aktien |
| VILLERE ST DENIS J & CO LLC | $20.635.017 | 97.996 | 0,17% | Aktien |
| DEARBORN PARTNERS LLC | $19.908.457 | 94.546 | 0,17% | Aktien |
| AVIVA PLC | $19.756.309 | 93.823 | 0,17% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $19.437.615 | 92.310 | 0,16% | Aktien |
| ROYAL BANK OF CANADA | $19.317.000 | 91.739 | 0,16% | Aktien |
| Foresight Group Ltd Liability Partnership | $18.809.622 | 89.732 | 0,16% | Aktien |
| Foster Victor Wealth Advisors, LLC | $18.687.169 | 89.528 | 0,16% | Aktien |
| STRS OHIO | $18.415.610 | 87.456 | 0,15% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $18.400.870 | 87.386 | 0,15% | Aktien |
| Baird Financial Group, Inc. | $17.982.467 | 85.399 | 0,15% | Aktien |
| GAMCO INVESTORS, INC. ET AL | $17.875.077 | 84.889 | 0,15% | Aktien |
| Trexquant Investment LP | $17.838.648 | 84.716 | 0,15% | Aktien |
| SPEECE THORSON CAPITAL GROUP INC | $17.792.000 | 84.495 | 0,15% | Aktien |
| GDS Wealth Management | $17.655.491 | 83.846 | 0,15% | Aktien |
| Cerity Partners LLC | $17.047.556 | 80.959 | 0,14% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $16.788.746 | 79.730 | 0,14% | Aktien |
| Addenda Capital Inc. | $16.444.043 | 78.093 | 0,14% | Aktien |
| NICHOLAS COMPANY, INC. | $16.425.513 | 78.005 | 0,14% | Aktien |
| APG Asset Management N.V. | $16.266.915 | 88.322 | 0,14% | Aktien |
| Copeland Capital Management, LLC | $16.262.620 | 77.231 | 0,14% | Aktien |
| Assenagon Asset Management S.A. | $16.095.971 | 76.440 | 0,14% | Aktien |
| UBS Group AG | $15.998.266 | 75.976 | 0,13% | Aktien |
| GHP Investment Advisors, Inc. | $15.393.129 | 69.611 | 0,13% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $15.360.450 | 72.947 | 0,13% | Aktien |
| Congress Wealth Management LLC / DE / | $15.239.267 | 63.437 | 0,13% | Aktien |
Unternehmensinsider 31 Insider · 16 Führungskräfte · 9 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel A Carestio | President and CEO | 4. Juni 2026 F | 63.647 | 0 | 1 | $-655.511 |
| Walter M Rosebrough Jr | President & CEO | 9. November 2020 S | 51.405 | 0 | 0 | $0 |
| Karen L Burton | Sr. Vice Pres., CFO | 4. Juni 2026 F | 13.184 | 0 | 0 | $0 |
| Michael J Tokich | Sr. Vice Pres., CFO | 31. Mai 2023 A | 42.464 | 0 | 0 | $0 |
| John Adam Zangerle | Sr. VP, Gen Counsel, and Sec. | 15. Juni 2026 S | 35.259 | 0 | 1 | $-296.968 |
| Kenneth E Kohler | SVP & GM, AST | 4. Juni 2026 F | 11.332 | 0 | 0 | $0 |
| Julia Madsen | Sr. VP and GM, Life Sciences | 4. Juni 2026 F | 12.257 | 0 | 0 | $0 |
| Mary Clare Fraser | SVP & Chief HRO | 4. Juni 2026 F | 13.716 | 0 | 0 | $0 |
| Renato Tamaro | V.P. & Corporate Treasurer | 4. Juni 2026 F | 6.194 | 0 | 0 | $0 |
| Lindsey Mcgowan | VP, Chf. Comp. & Quality Offc. | 2. Juni 2026 F | 5.656 | 0 | 0 | $0 |
| Cary L Majors | SVP and President, Healthcare | 2. Juni 2026 F | 17.338 | 0 | 0 | $0 |
| Andrew Xilas | SVP and GM, Dental | 4. Dezember 2023 M | 6.471 | 0 | 0 | $0 |
| Kathleen Bardwell | Sr.V. P. & C.C.O. | 28. Juni 2019 M | 17.428 | 0 | 0 | $0 |
| Adrian Vincent Coward | Sr. V P, Healthcare Spec Serv | 31. Mai 2019 A | 25.119 | 0 | 0 | $0 |
| Gulam Amjad Khan | Sr. V.P., Procedural Solutions | 31. Mai 2019 A | 14.685 | 0 | 0 | $0 |
| Michiel Dezwaan | V.P., Human Resources & CHRO | 28. März 2019 A | 30 | 0 | 0 | $0 |
| Richard C Breeden | Direktor | 2. Juni 2026 M | 38.964 | 0 | 1 | $-310.284 |
| Richard Martin Steeves | Direktor | 3. August 2023 A | 0 | 0 | 0 | $0 |
| Jacqueline B Kosecoff | Direktor | 3. August 2023 A | 0 | 0 | 0 | $0 |
| David B Lewis | Direktor | 21. Juli 2021 M | 8.245 | 0 | 0 | $0 |
| Loyal W Wilson | Direktor | 4. Juni 2019 M | 24.000 | 0 | 0 | $0 |
| Michael B Wood | Direktor | 16. Mai 2019 S | 16.631 | 0 | 0 | $0 |
| Duncan K Nichol | Direktor | 28. März 2019 A | — | 0 | 0 | $0 |
| Mohsen Sohi | — | 12. August 2026 M | 24.305 | 0 | 1 | $-956.795 |
| Pierre Boulud | — | 10. August 2026 A | — | 0 | 0 | $0 |
| Louis Shapiro | — | 10. August 2026 A | — | 0 | 0 | $0 |
| Esther M. Alegria | — | 10. August 2026 A | — | 0 | 0 | $0 |
| Nirav R Shah | — | 10. August 2026 A | 292 | 0 | 0 | $0 |
| Paul Edward Martin | — | 10. August 2026 A | — | 0 | 0 | $0 |
| Christopher S Holland | — | 10. August 2026 A | 67 | 0 | 0 | $0 |
| Cynthia L Feldmann | — | 10. August 2026 A | 705 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| STERIS plc, Solar New US Holding Co, LLC, Crystal Merger Sub 1, LLC | 22. Januar 2021 | — | Erste Einreichung | M&A / Verkauf | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 117 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IHI · iShares Trust | 3,22% | 464.734 SH | 8. August 2026 | Täglich |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,05% | 15.823 SH | 8. August 2026 | Täglich |
| RUNN · Strategic Trust | 1,75% | 28.510 NS | 31. Mai 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,73% | 56.988 SH | 8. August 2026 | Täglich |
| NUMV · Nushares ETF Trust | 1,32% | 26.177 NS | 30. April 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 0,95% | 1.976 NS | 30. April 2026 | N-PORT |
| SUSA · iShares Trust | 0,68% | 121.336 SH | 8. August 2026 | Täglich |
| EVUS · iShares Trust | 0,56% | 9.151 SH | 8. August 2026 | Täglich |
| NULV · Nushares ETF Trust | 0,39% | 37.765 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,37% | 58.541 SH | 8. August 2026 | Täglich |
| VFMV · VANGUARD WELLINGTON FUND | 0,33% | 6.491 SH | 8. August 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,31% | 1.957 NS | 30. April 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,30% | 294.875 SH | 8. August 2026 | Täglich |
| IXJ · iShares Trust | 0,29% | 51.423 SH | 8. August 2026 | Täglich |
| ESGU · iShares Trust | 0,26% | 201.599 SH | 8. August 2026 | Täglich |
| IDMO · Invesco Exchange-Traded Fund Trust … | 0,23% | 1.233.257 SH | 8. August 2026 | Täglich |
| VOT · VANGUARD INDEX FUNDS | 0,23% | 375.677 SH | 8. August 2026 | Täglich |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,23% | 4.299 NS | 31. Mai 2026 | N-PORT |
| ESLG · Strategy Shares | 0,22% | 200 NS | 30. April 2026 | N-PORT |
| IWS · iShares Trust | 0,22% | 146.438 SH | 8. August 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 891.100 SH | 8. August 2026 | Täglich |
| ESUM · Strategy Shares | 0,20% | 1.429 NS | 30. April 2026 | N-PORT |
| VO · VANGUARD INDEX FUNDS | 0,20% | 2.125.301 SH | 8. August 2026 | Täglich |
| SIZE · iShares Trust | 0,20% | 3.770 SH | 8. August 2026 | Täglich |
| SPHQ · Invesco Exchange-Traded Fund Trust | 0,20% | 164.233 SH | 8. August 2026 | Täglich |
| EUSA · iShares, Inc. | 0,19% | 15.888 SH | 8. August 2026 | Täglich |
| IMCV · iShares Trust | 0,18% | 9.064 SH | 8. August 2026 | Täglich |
| VOE · VANGUARD INDEX FUNDS | 0,18% | 315.003 SH | 8. August 2026 | Täglich |
| DFLV · Dimensional ETF Trust | 0,17% | 45.657 NS | 30. April 2026 | N-PORT |
| IWR · iShares Trust | 0,16% | 398.593 SH | 8. August 2026 | Täglich |
| PDN · Invesco Exchange-Traded Fund Trust … | 0,16% | 71.272 SH | 8. August 2026 | Täglich |
| IMCB · iShares Trust | 0,16% | 11.359 SH | 8. August 2026 | Täglich |
| IDHQ · Invesco Exchange-Traded Fund Trust … | 0,14% | 174.374 SH | 8. August 2026 | Täglich |
| IMCG · iShares Trust | 0,13% | 22.803 SH | 8. August 2026 | Täglich |
| XOEF · iShares Trust | 0,12% | 122 SH | 8. August 2026 | Täglich |
| ESLV · Strategy Shares | 0,12% | 65 NS | 30. April 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,11% | 3.730 SH | 8. August 2026 | Täglich |
| DFUV · Dimensional ETF Trust | 0,10% | 67.186 NS | 30. April 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,10% | 130.000 | 8. August 2026 | Täglich |
| CATH · Global X Funds | 0,10% | 5.522 NS | 30. April 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,09% | 554.067 SH | 8. August 2026 | Täglich |
| PFM · Invesco Exchange-Traded Fund Trust | 0,08% | 2.778 SH | 8. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,08% | 1.487 NS | 30. April 2026 | N-PORT |
| VTV · VANGUARD INDEX FUNDS | 0,08% | 931.689 SH | 8. August 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,08% | 16.351 SH | 8. August 2026 | Täglich |
| AUSF · Global X Funds | 0,07% | 2.763 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,07% | 9.256 NS | 30. April 2026 | N-PORT |
| SUSL · iShares Trust | 0,06% | 3.391 SH | 8. August 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,06% | 132.795 NS | 30. April 2026 | N-PORT |
| DSI · iShares Trust | 0,06% | 15.225 SH | 8. August 2026 | Täglich |